Raquel Pinacho

Raquel Pinacho

Auto-generated profile, based on publicly available information

Raquel Pinacho

Department of Experimental Psychology University of Oxford Oxford UK

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2015 in Journal of Psychiatric Research
Verified
Journal Article
Closed access
BABelén Ansoleaga
Belén Ansoleaga
PGPaula Garcia-Esparcia
Paula Garcia-Esparcia
RPRaquel Pinacho
Raquel Pinacho
JHJosep Maria Haro
Josep Maria Haro
BRBelen Ramos
Belen Ramos
Isidro FerrerIsidro Ferrer
Isidro Ferrer

1 August 2011 in Bipolar Disorders
Verified
Journal Article
Closed access
PDF file
RPRaquel Pinacho
Raquel Pinacho
NVNuria Villalmanzo
Nuria Villalmanzo
JLJasmin Lalonde
Jasmin Lalonde
JHJosep Maria Haro
Josep Maria Haro
JMJ Javier Meana
J Javier Meana
BRBelen Ramos
Belen Ramos

1 July 2013 in Journal of Psychiatric Research
Verified
Journal Article
Closed access
RPRaquel Pinacho
Raquel Pinacho
NVNúria Villalmanzo
Núria Villalmanzo
MRMercedes Roca
Mercedes Roca
RIRaquel Iniesta
Raquel Iniesta
AMAlfonso Monje
Alfonso Monje
BRBelen Ramos
Belen Ramos

1 October 2017 in Progress in Neuro-Psychopharmacology and Biological Psychiatry
Verified
Journal Article
Closed access
KMKarina MacDowell
Karina MacDowell
RPRaquel Pinacho
Raquel Pinacho
JLJuan C. Leza
Juan C. Leza
JCJoan Costa
Joan Costa
BRBelen Ramos
Belen Ramos
BGBorja García-Bueno
Borja García-Bueno

1 November 2016 in Schizophrenia Research
Verified
Journal Article
Open access
RPRaquel Pinacho
Raquel Pinacho
NVNúria Villalmanzo
Núria Villalmanzo
JMJ Javier Meana
J Javier Meana
IFIsidre Ferrer
Isidre Ferrer
ABAdriana Berengueras
Adriana Berengueras
BRBelen Ramos
Belen Ramos
Schizophrenia constitutes a complex disease. Negative and cognitive symptoms are enduring and debilitating components of the disorder, highly associated to disability and burden. Disrupted neurotransmission circuits in dorsolateral prefrontal cortex (DLPFC) have been related to these symptoms. To identify candidates altered in schizophrenia, we performed a pilot proteomic analysis on postmortem human DLPFC tissue from patients with schizophrenia (n=4) and control (n=4) subjects in a pool design using differential isotope peptide labelling followed by liquid chromatography tandem mass spectrometry (LC-MS/MS). We quantified 1315 proteins with two or more unique peptides, 116 of which showed altered changes. Of these altered proteins, we selected four with potential roles on cell signaling, neuronal development and synapse functioning for further validation: casein kinase I isoform epsilon (CSNK1E), fatty acid-binding protein 4 (FABP4), neurofilament triplet H protein (NEFH), and retinal dehydrogenase 1 (ALDH1A1). Immunoblot validation confirmed our proteomic findings of these proteins being decreased in abundance in the schizophrenia samples. Additionally, we conducted immunoblot validation of these candidates on an independent sample cohort comprising 23 patients with chronic schizophrenia and 23 matched controls. In this second cohort, CSNK1E, FABP4 and NEFH were reduced in the schizophrenia group while ALDH1A1 did not significantly change. This study provides evidence indicating these proteins are decreased in schizophrenia: CSNK1E, involved in circadian molecular clock signaling, FABP4 with possible implication in synapse functioning, and NEFH, important for cytoarchitecture organization. Hence, these findings suggest the possible implication of these proteins in the cognitive and/or negative symptoms in schizophrenia.

1 November 2013 in Journal of Psychiatric Research
Verified
Journal Article
Closed access
MFMontserrat Fusté
Montserrat Fusté
RPRaquel Pinacho
Raquel Pinacho
IMIria Meléndez-Pérez
Iria Meléndez-Pérez
NVNúria Villalmanzo
Núria Villalmanzo
VVVictoria Villalta-Gil
Victoria Villalta-Gil
BRBelen Ramos
Belen Ramos